Meghan Marie Gagnon is a pharmacist who is specialized in Oncology in New Haven, Connecticut. Patients can reach her at 20 York St, New Haven or contact her on 203-688-4242. Active license number of Meghan Marie Gagnon is PCT.0016173 for Oncology in Connecticut. Meghan Marie Gagnon is a licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.
Complete Profile:
Meghan Marie Gagnon speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Meghan Marie Gagnon
Specialization:
Oncology
Credentials:
PHARMD
Gender:
Female
Location:
20 York St, New Haven, Connecticut, 06510-3220
Phone:
203-688-4242
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Meghan Marie Gagnon are as mentioned below.
NPI Number:
1619851318
NPI Enumeration Date:
05 Aug, 2025
NPI Last Update On:
05 Aug, 2025
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Meghan Marie Gagnon are as mentioned below.
Specialization
License Number
State
Status
Oncology
PCT.0016173
Connecticut
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
54 Park St, Wallingford, Connecticut
Zip:
06492-4426
Phone Number:
--
Fax Number:
--
Patients can reach Meghan Marie Gagnon at 20 York St, New Haven, Connecticut or can call on phone at 203-688-4242.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 13 October, 2025.